You've heard a LOT about semaglutide (e.g. Ozempic, Wegovy)/GLP-1 medications in both diabetes care and for intentional weight loss.
Are you clients/patients/communities asking questions about this class of medications?
Are you looking for more support in how to navigate these conversations with them, honoring body autonomy, informed consent, and your weight-inclusive approach?
Join us for this webinar on Wednesday Aug 23 at 12pm EST (one hour), featuring Dr. Erin Knopf CEDS, Lauren Newman RD CDCES CEDS, Erin Ebert LCSW, and Dr. Rebecca Berens MD. Moderated by Heather Caplan RDN.
Participants will be able to:
Describe mechanisms of these medications, including intended uses, doses, side effects, etc.
Understand current literature on the usage of these medications for both diabetes management and weight loss.
Use the information to guide their patient education and medical nutrition therapy counseling in a variety of client and patient populations.
In application for 1 CEU for Registered Dietitian Nutritionists.
This webinar will be recorded and available to replay for up to 30 days.
weightinclusivenutrition.com
